BETA-2 MICROGLOBULIN IN MULTIPLE-MYELOMA

被引：82

作者：

ALEXANIAN, R

BARLOGIE, B

FRITSCHE, H

机构：

来源：

关键词：

D O I：

10.1002/ajh.2830200405

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：345 / 351

页数：7

共 17 条

[1] ALEXANIAN R, 1975, CANCER, V36, P1192, DOI 10.1002/1097-0142(197510)36:4<1192::AID-CNCR2820360403>3.0.CO
[2] 2-I
[3] ALEXANIAN R, 1984, CANCER, V53, P583, DOI 10.1002/1097-0142(19840201)53:3<583::AID-CNCR2820530336>3.0.CO
[4] 2-1
[5] MARROW CYTOMETRY AND PROGNOSIS IN MYELOMA
BARLOGIE, B
ALEXANIAN, R
GEHAN, EA
SMALLWOOD, L
SMITH, T
DREWINKO, B
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1983, 72 (03) : 853 - 861
[6] EFFECTIVE TREATMENT OF ADVANCED MULTIPLE-MYELOMA REFRACTORY TO ALKYLATING-AGENTS
BARLOGIE, B
SMITH, L
ALEXANIAN, R
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (21) : 1353 - 1356
[7] BATAILLE R, 1984, BLOOD, V63, P468
[8] SERUM BETA-2-MICROGLOBULIN IN MULTIPLE-MYELOMA - RELATION TO PRESENTING FEATURES AND CLINICAL STATUS
BATAILLE, R
MAGUB, M
GRENIER, J
DONNADIO, D
SANY, J
[J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (01): : 59 - 66
[9] SERUM BETA-2-MICROGLOBULIN AND SURVIVAL DURATION IN MULTIPLE-MYELOMA - A SIMPLE RELIABLE MARKER FOR STAGING
BATAILLE, R
DURIE, BGM
GRENIER, J
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 1983, 55 (03) : 439 - 447
[10] CASSUTO JP, 1978, LANCET, V2, P108